Cancer Center of Central Connecticut

Southington, Connecticut 06489

Use our guide to learn which trials are right for you!

We've found
19 trials
at this facility
B-Cell Chronic Lymphocytic Leukemia Clinical Trial
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Status: Enrolling, Phase III
Updated: 10/20/2015
mi
from
Southington, CT
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase III
Updated: 3/25/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 1/22/2015
mi
from
Southington, CT
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)
Status: Enrolling, Phase III
Updated: 3/1/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Metastatic gpNMB Over-expressing Triple Negative Breast Cancer. Clinical Trial
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Open Label, Randomized Phase 2b Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who do Not Have Favorable Imatinib Response (DASCERN)
Status: Enrolling, Phase II
Updated: 11/18/2015
mi
from
Southington, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies
Status: Enrolling, Phase II
Updated: 2/5/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
mi
from
Southington, CT
Click here to add this to my saved trials
Oncology Clinical Trial
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
Status: Enrolling, Phase III
Updated: 12/15/2015
mi
from
Southington, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma
Status: Enrolling, Phase I
Updated: 3/11/2015
mi
from
Southington, CT
Click here to add this to my saved trials
Relapsed or Refractory Chronic Lymphocytic Leukemia Clinical Trial
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Status: Enrolling, Phase II
Updated: 3/30/2016
mi
from
Southington, CT
Click here to add this to my saved trials
B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion Clinical Trial
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion
Status: Enrolling, Phase II
Updated: 3/21/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or HerceptinĀ® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
Status: Enrolling, Phase III
Updated: 2/1/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Chronic Phase Chronic Myeloid Leukemia Clinical Trial
This Study Will be a Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib
Status: Enrolling, Phase IV
Updated: 3/28/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 2/9/2016
mi
from
Southington, CT
Click here to add this to my saved trials
Idiopathic Thrombocytopenic Purpura Clinical Trial
IGIV Study for Chronic ITP Patients Ages 3-70
Status: Enrolling, Phase III
Updated: 2/17/2016
mi
from
Southington, CT
Click here to add this to my saved trials